Antibody reactivity to a synthetic peptide (P62) of the Epstein-Barr nuclear antigen in sera of patients with X-linked lymphoproliferative syndrome

Geoffrey Milton Thiele, Molly Bicak, Helen Grierson, Patrick Lai, Purtilo David

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

An enzyme-linked immunosorbent assay (ELISA) was used to measured IgG antiboody titers againt a synthetic peptide whose sequence was derived from the glycine-alanine repeating region of Epstein-Barr virus nuclear associated antigen 1 (EBNA-1). Antibody titers were determined in sera from 15 normal subjects, sera from 21 normal male siblings of X-linked lymphoproliferative syndrome (XLP) patients, from 20 XLP patients comprising a total of 42 samples, and ten samples before and ten samples after gamma-globulin therapy in ten patients with XLP. Data analysis demonstrated that while there are differences between the ELISA and ACIF, they appear to measure a similar response as demonstrated by their correlation coefficient (0.77) and the GMT to EBNA observed by both methods. No cross-reactivity of cytomegalovirus antibodies to the EBNA-1 peptide was observed by immunobv using adsorption against AD-169 infected MRC-5 cells.. However, non-specific binding was observed if samples were not pre-incubated in a 10% goat serum PBS-Tween 20 solution. This pre-treatment removed the non-specific binding that falsely elevated GMT in approximately 15% of both normal and XLP samples in ELISA. The ELISA system appears to be a sensitive, reproducible and objective test that may be useful for assessing the antibody responses of patients to the EBNA-1 protein.

Original languageEnglish (US)
Pages (from-to)249-259
Number of pages11
JournalJournal of Immunological Methods
Volume100
Issue number1-2
DOIs
StatePublished - Jun 26 1987

Fingerprint

Nuclear Antigens
Lymphoproliferative Disorders
Epstein-Barr Virus Nuclear Antigens
Enzyme-Linked Immunosorbent Assay
Antibodies
Serum
Peptides
Polysorbates
gamma-Globulins
Cytomegalovirus
Goats
Alanine
Glycine
Adsorption
Antibody Formation
Siblings
Immunoglobulin G
P62 peptide
Therapeutics
Proteins

Keywords

  • (Antibody)
  • ELISA
  • Epstein-Barr nuclear antigen
  • Epstein-Barr viru
  • Synthetic peptides

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Antibody reactivity to a synthetic peptide (P62) of the Epstein-Barr nuclear antigen in sera of patients with X-linked lymphoproliferative syndrome. / Thiele, Geoffrey Milton; Bicak, Molly; Grierson, Helen; Lai, Patrick; David, Purtilo.

In: Journal of Immunological Methods, Vol. 100, No. 1-2, 26.06.1987, p. 249-259.

Research output: Contribution to journalArticle

@article{b5ddba6429fb402783ceb5f7112d5952,
title = "Antibody reactivity to a synthetic peptide (P62) of the Epstein-Barr nuclear antigen in sera of patients with X-linked lymphoproliferative syndrome",
abstract = "An enzyme-linked immunosorbent assay (ELISA) was used to measured IgG antiboody titers againt a synthetic peptide whose sequence was derived from the glycine-alanine repeating region of Epstein-Barr virus nuclear associated antigen 1 (EBNA-1). Antibody titers were determined in sera from 15 normal subjects, sera from 21 normal male siblings of X-linked lymphoproliferative syndrome (XLP) patients, from 20 XLP patients comprising a total of 42 samples, and ten samples before and ten samples after gamma-globulin therapy in ten patients with XLP. Data analysis demonstrated that while there are differences between the ELISA and ACIF, they appear to measure a similar response as demonstrated by their correlation coefficient (0.77) and the GMT to EBNA observed by both methods. No cross-reactivity of cytomegalovirus antibodies to the EBNA-1 peptide was observed by immunobv using adsorption against AD-169 infected MRC-5 cells.. However, non-specific binding was observed if samples were not pre-incubated in a 10{\%} goat serum PBS-Tween 20 solution. This pre-treatment removed the non-specific binding that falsely elevated GMT in approximately 15{\%} of both normal and XLP samples in ELISA. The ELISA system appears to be a sensitive, reproducible and objective test that may be useful for assessing the antibody responses of patients to the EBNA-1 protein.",
keywords = "(Antibody), ELISA, Epstein-Barr nuclear antigen, Epstein-Barr viru, Synthetic peptides",
author = "Thiele, {Geoffrey Milton} and Molly Bicak and Helen Grierson and Patrick Lai and Purtilo David",
year = "1987",
month = "6",
day = "26",
doi = "10.1016/0022-1759(87)90196-7",
language = "English (US)",
volume = "100",
pages = "249--259",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Antibody reactivity to a synthetic peptide (P62) of the Epstein-Barr nuclear antigen in sera of patients with X-linked lymphoproliferative syndrome

AU - Thiele, Geoffrey Milton

AU - Bicak, Molly

AU - Grierson, Helen

AU - Lai, Patrick

AU - David, Purtilo

PY - 1987/6/26

Y1 - 1987/6/26

N2 - An enzyme-linked immunosorbent assay (ELISA) was used to measured IgG antiboody titers againt a synthetic peptide whose sequence was derived from the glycine-alanine repeating region of Epstein-Barr virus nuclear associated antigen 1 (EBNA-1). Antibody titers were determined in sera from 15 normal subjects, sera from 21 normal male siblings of X-linked lymphoproliferative syndrome (XLP) patients, from 20 XLP patients comprising a total of 42 samples, and ten samples before and ten samples after gamma-globulin therapy in ten patients with XLP. Data analysis demonstrated that while there are differences between the ELISA and ACIF, they appear to measure a similar response as demonstrated by their correlation coefficient (0.77) and the GMT to EBNA observed by both methods. No cross-reactivity of cytomegalovirus antibodies to the EBNA-1 peptide was observed by immunobv using adsorption against AD-169 infected MRC-5 cells.. However, non-specific binding was observed if samples were not pre-incubated in a 10% goat serum PBS-Tween 20 solution. This pre-treatment removed the non-specific binding that falsely elevated GMT in approximately 15% of both normal and XLP samples in ELISA. The ELISA system appears to be a sensitive, reproducible and objective test that may be useful for assessing the antibody responses of patients to the EBNA-1 protein.

AB - An enzyme-linked immunosorbent assay (ELISA) was used to measured IgG antiboody titers againt a synthetic peptide whose sequence was derived from the glycine-alanine repeating region of Epstein-Barr virus nuclear associated antigen 1 (EBNA-1). Antibody titers were determined in sera from 15 normal subjects, sera from 21 normal male siblings of X-linked lymphoproliferative syndrome (XLP) patients, from 20 XLP patients comprising a total of 42 samples, and ten samples before and ten samples after gamma-globulin therapy in ten patients with XLP. Data analysis demonstrated that while there are differences between the ELISA and ACIF, they appear to measure a similar response as demonstrated by their correlation coefficient (0.77) and the GMT to EBNA observed by both methods. No cross-reactivity of cytomegalovirus antibodies to the EBNA-1 peptide was observed by immunobv using adsorption against AD-169 infected MRC-5 cells.. However, non-specific binding was observed if samples were not pre-incubated in a 10% goat serum PBS-Tween 20 solution. This pre-treatment removed the non-specific binding that falsely elevated GMT in approximately 15% of both normal and XLP samples in ELISA. The ELISA system appears to be a sensitive, reproducible and objective test that may be useful for assessing the antibody responses of patients to the EBNA-1 protein.

KW - (Antibody)

KW - ELISA

KW - Epstein-Barr nuclear antigen

KW - Epstein-Barr viru

KW - Synthetic peptides

UR - http://www.scopus.com/inward/record.url?scp=0023274198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023274198&partnerID=8YFLogxK

U2 - 10.1016/0022-1759(87)90196-7

DO - 10.1016/0022-1759(87)90196-7

M3 - Article

C2 - 3036951

AN - SCOPUS:0023274198

VL - 100

SP - 249

EP - 259

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -